BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

892 related articles for article (PubMed ID: 35906199)

  • 1. Radiotherapy combined with immunotherapy: the dawn of cancer treatment.
    Zhang Z; Liu X; Chen D; Yu J
    Signal Transduct Target Ther; 2022 Jul; 7(1):258. PubMed ID: 35906199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abscopal effect of radiotherapy combined with immune checkpoint inhibitors.
    Liu Y; Dong Y; Kong L; Shi F; Zhu H; Yu J
    J Hematol Oncol; 2018 Aug; 11(1):104. PubMed ID: 30115069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy-immunotherapy combinations - perspectives and challenges.
    Mondini M; Levy A; Meziani L; Milliat F; Deutsch E
    Mol Oncol; 2020 Jul; 14(7):1529-1537. PubMed ID: 32112478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy Dose in Patients Receiving Immunotherapy.
    Fitzgerald KJ; Schoenfeld JD
    Semin Radiat Oncol; 2023 Jul; 33(3):327-335. PubMed ID: 37331787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in the combination of radiotherapy and immunotherapy for breast cancer.
    Zhang R; Clark SD; Guo B; Zhang T; Jeansonne D; Jeyaseelan SJ; Francis J; Huang W
    Expert Rev Anticancer Ther; 2023 Apr; 23(4):375-383. PubMed ID: 37039098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect.
    Rodríguez-Ruiz ME; Vanpouille-Box C; Melero I; Formenti SC; Demaria S
    Trends Immunol; 2018 Aug; 39(8):644-655. PubMed ID: 30001871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and evidence to combine radiation therapy and immunotherapy for cancer treatment.
    Ishihara D; Pop L; Takeshima T; Iyengar P; Hannan R
    Cancer Immunol Immunother; 2017 Mar; 66(3):281-298. PubMed ID: 27743027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology-enhanced radiotherapy and the abscopal effect: Current status and challenges of nanomaterial-based radio-immunotherapy.
    Viswanath D; Park J; Misra R; Pizzuti VJ; Shin SH; Doh J; Won YY
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(1):e1924. PubMed ID: 37632203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abscopal Effect Following Immunotherapy and Combined Stereotactic Body Radiation Therapy in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma: A Report of Two Cases and Literature Review.
    Choi JS; Sansoni ER; Lovin BD; Lindquist NR; Phan J; Mayo LL; Ferrarotto R; Su SY
    Ann Otol Rhinol Laryngol; 2020 May; 129(5):517-522. PubMed ID: 31875405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On target methods to induce abscopal phenomenon for Off-Target effects: From happenstance to happenings.
    Nelson BE; Adashek JJ; Lin SH; Subbiah V
    Cancer Med; 2023 Mar; 12(6):6451-6465. PubMed ID: 36411943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?
    Lee L; Matulonis U
    Gynecol Oncol; 2019 Jul; 154(1):236-245. PubMed ID: 30995960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy and the immune system: More than just immune suppression.
    Rückert M; Flohr AS; Hecht M; Gaipl US
    Stem Cells; 2021 Sep; 39(9):1155-1165. PubMed ID: 33961721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations.
    Colton M; Cheadle EJ; Honeychurch J; Illidge TM
    Radiat Oncol; 2020 Nov; 15(1):254. PubMed ID: 33148287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy combination opportunities leveraging immunity for the next oncology practice.
    Herrera FG; Bourhis J; Coukos G
    CA Cancer J Clin; 2017 Jan; 67(1):65-85. PubMed ID: 27570942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The abscopal effect: a sense of DNA damage is in the air.
    Lippert TP; Greenberg RA
    J Clin Invest; 2021 May; 131(9):. PubMed ID: 33938453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abscopal effect: Myth or reality?].
    Mirjolet C; Truc G
    Cancer Radiother; 2021 Oct; 25(6-7):533-536. PubMed ID: 34462213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune targets in the tumor microenvironment treated by radiotherapy.
    Ozpiskin OM; Zhang L; Li JJ
    Theranostics; 2019; 9(5):1215-1231. PubMed ID: 30867826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Abscopal Effect: A Review of Pre-Clinical and Clinical Advances.
    Janopaul-Naylor JR; Shen Y; Qian DC; Buchwald ZS
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute Lymphocyte Count Predicts Abscopal Responses and Outcomes in Patients Receiving Combined Immunotherapy and Radiation Therapy: Analysis of 3 Phase 1/2 Trials.
    Chen D; Verma V; Patel RR; Barsoumian HB; Cortez MA; Welsh JW
    Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):196-203. PubMed ID: 32036004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abscopal Effect, From Myth to Reality: From Radiation Oncologists' Perspective.
    Yilmaz MT; Elmali A; Yazici G
    Cureus; 2019 Jan; 11(1):e3860. PubMed ID: 30899611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.